Scorpius Holdings, Inc. SCPX

Full chart Compare
Set alert

Price alert · SCPX

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.14 +0.14 +23,650.00%

After hours · Nov 2, 4:00 PM ET

0.01 Day range 0.0111
0.0001 52-week range 0.10
YTD
+200.00%
1 year
-53.85%
Market cap
36.69K
Revenue (ttm)
9.85M
EPS (ttm)
-4.18
Shares out
4.33M
Forward P/E
-0.11
YTD return
+200.00%
1-year return
-53.85%
Volume
60.81K
Avg volume
8.79K
Open
0.01
Previous close
0.0006
Day's range
0.01 – 0.0111
52-week range
0.0001 – 0.10
Beta
-0.33
Price target
5.00 (+833233.3%)

2Y -0.7344 (-99.92%)

0.00000.5000Jan 25Jun 25Nov 25Mar 26Aug 260.0006

Key statistics

Enterprise value
12.72M
PEG ratio
0.00
Price / sales
0.14
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
15.50%
Free cash flow
-16.05M
Total cash
1.51M
Total debt
15.87M
Return on equity
-91.85%
Short % of float
3.22%
50-day average
0.6294
200-day average
0.57885

Financials — quick view

All financials
SCPX Revenue — quarterly 1.05M
2021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024
SCPX Net income — quarterly -9.40M
2021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024
SCPX EPS — quarterly -3.77
2021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024

Upgrades / downgrades

SCPX analyst upgrades and downgrades
DateFirmActionFromTo
May 1, 2023Brookline CapitaldownBuyHold
Apr 3, 2023Maxim GroupdownBuyHold
Mar 3, 2021Cantor Fitzgeraldinit—Overweight

About Scorpius Holdings, Inc.

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on SCPX — it syncs with the Stock Master app.

Insider holders

SCPX insider holders
InsiderRelationLatest transactionDateShares held
WOLF JEFFREY ALAN J.D.Chief Executive OfficerStock Award(Grant)May 15, 20243,594,040

Institution ownership

SCPX institution ownership
Holder% heldSharesValueReported
Sabby Management, LLC1.36%346,256107.48KSep 29, 2024
Warberg Asset Management LLC0.37%95,00029.49KSep 29, 2024
Altium Capital Management, LP0.35%88,29127.41KSep 29, 2024
HRT Financial LP0.20%51,60116.02KSep 29, 2024
UBS Group AG0.08%19,2905.99KSep 29, 2024
Geode Capital Management, LLC0.06%15,9044.94KSep 29, 2024

Fund ownership

SCPX fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.06%15,6054.84KOct 30, 2024
Fidelity Series Total Market Index Fund0.01%3,4511.07KOct 30, 2024